Refractory, locally advanced Non-small cell lung cancer
Also known as: Refractory, locally advanced Non small cell lung cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB09063 | Ceritinib | An antineoplastic kinase inhibitor used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients with inadequate clinical response or intolerance to crizotinib. |
DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
Drug | Drug Name | Phase | Status | Count |
---|